On the Immunotherapy for Tumors

Abstract

Tumor immunotherapy has made major strides in recent years, greatly enhancing the survival rate of cancer patients. Tumor vaccines, cellular immunotherapy, immunomodulatory medicines targeting T cells, immune checkpoint inhibitors (ICIs), and other forms of immunotherapy treatments have all developed one after the other. As new high-tech technologies emerge, tumor immunotherapy techniques are also continuously improved.